Vaccine Therapies Show Promise In Fight Against Cervical Cancer
Executive Summary
The eradication of cervical cancer is on the horizon, stirring further competition between biopharma companies developing novel cancer vaccines.
You may also be interested in...
US NCI’s Gravitt On Stepping Up Cancer Control Efforts In Asia-Pacific
Dr Patti Gravitt, Deputy Director, Center for Global Health, US National Cancer Institute, in an interview with Scrip, discusses a range of strategies underway and proposed to strengthen cancer control efforts in the Asia Pacific. HPV vaccination and a regional cancer control dashboard are among the areas she highlighted.
Merck & Co. Pounces On Moderna mRNA-Based Cancer Vaccine Option
The company will pay Moderna $250m upfront to develop and commercialize a personalized cancer vaccine for melanoma in combination with Keytruda.
Serum Scores A Double - HPV Vaccine In India, Novavax Vaccine In US
Serum Institute will supply initial doses of NVX-CoV2373 in the US, but late approvals have meant Novavax's vaccine is facing weak demand and surplus stocks in other parts of the world. Meanwhile, Serum has also secured a nod in India for the first indigenously-developed HPV vaccine, also the fifth globally.